Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 63 (1), 39-45

P-27/HP Endolysin as Antibacterial Agent for Antibiotic Resistant Staphylococcus Aureus of Human Infections

Affiliations

P-27/HP Endolysin as Antibacterial Agent for Antibiotic Resistant Staphylococcus Aureus of Human Infections

Ragini Gupta et al. Curr Microbiol.

Abstract

Staphylococcus aureus causes a wide range of suppurative infections in humans and animals. Due to its high virulence, ability to adopt various environmental conditions, and acquired multiple drug resistance, treatment of such infections has become difficult. Therefore, there is an immense need to develop alternate drug modalities to control this pathogen. In past few years, phage-encoded endolysin therapy has emerged as a new hope not only due to its ability to specifically kill the target bacteria irrespective of their antibiotic sensitivity but also because of minimum or no side effects, a problem associated with antibiotic therapy. In this article, we report purification of a broad spectrum anti-staphylococcal endolysin (P-27/HP endolysin) encoded by phage P-27/HP isolated from sewage water. On SDS-PAGE endolysin resolved in three polypeptides of molecular weights 33.5, 48.6, and 62.2 kDa. Endolysin exhibited maximum in vitro lytic activity at temperature between 35 and 40°C and pH 7.0. In vivo experiments revealed considerable (99.9%) elimination of S. aureus 27/HP from spleens of endolysin-treated mice and had saved them from death due to bacteremia caused by S. aureus 27/HP challenge infection. Thus, P-27/HP endolysin offers suitable substitute of antibiotics to control S. aureus infections.

Similar articles

See all similar articles

Cited by 15 PubMed Central articles

See all "Cited by" articles

References

    1. J Infect Dis. 2003 Feb 15;187(4):613-24 - PubMed
    1. Antimicrob Agents Chemother. 2005 Jul;49(7):2934-40 - PubMed
    1. J Appl Microbiol. 2008 Jan;104(1):1-13 - PubMed
    1. Crit Care Med. 2009 Feb;37(2):642-9 - PubMed
    1. Curr Opin Microbiol. 2005 Aug;8(4):480-7 - PubMed

MeSH terms

Feedback